top of page
Home
Solutions
Treatment Selection
LiquidHALLMARK®
Screening & Health Risk Assessment
CardioHemeRISK™
Treatment Selection
LiquidHALLMARK®
Screening & Health Risk Assessment
CardioHemeRISK™
Communities
Oncologists
Patients
Insurers
Investors
Oncologists
Patients
Insurers
Investors
Knowledge Center
Publications
News & Updates
Patient Stories
Webinars
Case Studies
Publications
News & Updates
Patient Stories
Webinars
Case Studies
About Us
About Lucence
Leadership
Careers
Contact Us
About Lucence
Leadership
Careers
Contact Us
Mobile menu (US)
Portal Login
Close
Home
Solutions
Screening and Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
LiquidSCREEN™ Lung
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
NPC GOLD™
Hereditary Risk Assessment
Lumi Series
Treat Response Monitoring
LucenceMONITOR™
Screening and Health Risk Assessment
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Treatment Selection
LiquidHALLMARK® & LiquidMARK™
LiquidSCREEN™ Lung
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
NPC GOLD™
Hereditary Risk Assessment
Lumi Series
Treat Response Monitoring
LucenceMONITOR™
Communities
Primary Care Doctors
Oncologists
Patients
Investors
Primary Care Doctors
Oncologists
Patients
Investors
Knowledge Center
Publications
News & Updates
Patient Stories
Webinars
Case Studies
Publications
News & Updates
Patient Stories
Webinars
Case Studies
About Lucence
About Lucence
Leadership
Careers
Contact Us
About Lucence
Leadership
Careers
Contact Us
Mobile menu (RoW)
Close
Solutions
篩查與健康風險評估
LucenceINSIGHT®
CardioHemeRISK™
LucenceLONGEVITY™
Menu
Close
治療方案選擇
LiquidHALLMARK® & LiquidMARK™
LiquidSCREEN™ Lung
HemeMARK™
UNITED™ 600
UNITED™ CNS
Rapid TissueMARK™
NPC GOLD™
Menu
Close
遺傳風險評估
Lumi Series
Menu
Close
治療反應監測
LucenceMONITOR™
Menu
Close
治療方案選擇
LiquidHALLMARK®
Menu
Close
Communities
社群
Oncologists
Patients
Insurers
Investors
Menu
Close
社群
Primary Care Doctors
Oncologists
Patients
Investors
Menu
Close
Knowledge Center
知識資源中心
Publications
News & Updates
Patient Stories
Webinars
Case Studies
Menu
Close
About Us
關於我們
About Lucence
Leadership
Careers
Contact Us
Menu
Close
Menu
Close
Solutions
篩查與健康風險評估
CardioHemeRISK™
Menu
Close
治療方案選擇
LiquidHALLMARK®
Menu
Close
Communities
社群
Oncologists
Patients
Insurers
Investors
Menu
Close
Knowledge Center
知識資源中心
Publications
News & Updates
Patient Stories
Webinars
Case Studies
Menu
Close
About Us
關於我們
About Lucence
Leadership
Careers
Contact Us
Menu
Close
Menu
Close
Portal Login
論文
篩選條件:
Year
Conference/Journal name
Publications
2016年6月29日
Tumor-derived circulating endothelial cell clusters in colorectal cancer
Read More
Tumor-derived circulating endothelial cell clusters in colorectal cancer
Publications
2015年1月1日
A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition
Read More
A Multigene Assay Identifying Distinct Prognostic Subtypes of Clear Cell Renal Cell Carcinoma with Differential Response to Tyrosine Kinase Inhibition
Go
Go
1
/
8
Go
Go
Like
bottom of page